Literature DB >> 32085692

Three-Dimensional Multilayered Microstructure Using Needle Array Bioprinting System.

Yasuhiro Shudo1, John W MacArthur1, Yoshihiro Kunitomi2, Lydia Joubert3, Masashi Kawamura1, Jiro Ono2, Akshara Thakore1, Kevin Jaatinen1, Anahita Eskandari1, Camille Hironaka1, Hye Sook Shin1, Yi-Ping Joseph Woo1.   

Abstract

Tissue engineering is an essential component of developing effective regenerative therapies. In this study, we introduce a promising method to create scaffold-free three-dimensional (3D) tissue engineered multilayered microstructures from cultured cells using the "3D tissue fabrication system" (Regenova®; Cyfuse, Tokyo, Japan). This technique utilizes the adhesive nature of cells. When cells are cultured in nonadhesive wells, they tend to aggregate and form a spheroidal structure. The advantage of this approach is that cellular components can be mixed into one spheroid, thereby promoting the formation of extracellular matrices, such as collagen and elastin. This system enables one to create a predesigned 3D structure composed of cultured cells. We found that the advantages of this system to be (1) the length, size, and shape of the structure that were designable and highly reproducible because of the computer controlled robotics system, (2) the graftable structure could be created within a reasonable period (8 days), and (3) the constructed tissue did not contain any foreign material, which may avoid the potential issues of contamination, biotoxicity, and allergy. The utilization of this robotic system enabled the creation of a 3D multilayered microstructure made of cell-based spheres with a satisfactory mechanical properties and abundant extracellular matrix during a short period of time. These results suggest that this new technology will represent a promising, attractive, and practical strategy in the field of tissue engineering. Impact statement The utilization of the "three dimensional tissue fabrication system" enabled the creation of a three-dimensional (3D) multilayered microstructure made of cell-based spheres with a satisfactory mechanical properties and abundant extracellular matrix during a short period of time. These results suggest that this new technology will represent a promising, attractive, and practical strategy in the field of tissue engineering.

Entities:  

Keywords:  biofabrication; extracellular matrix; scaffold free; three-dimensional; tissue engineering

Mesh:

Year:  2020        PMID: 32085692      PMCID: PMC7476375          DOI: 10.1089/ten.TEA.2019.0313

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  18 in total

1.  Metre-long cell-laden microfibres exhibit tissue morphologies and functions.

Authors:  Hiroaki Onoe; Teru Okitsu; Akane Itou; Midori Kato-Negishi; Riho Gojo; Daisuke Kiriya; Koji Sato; Shigenori Miura; Shintaroh Iwanaga; Kaori Kuribayashi-Shigetomi; Yukiko T Matsunaga; Yuto Shimoyama; Shoji Takeuchi
Journal:  Nat Mater       Date:  2013-03-31       Impact factor: 43.841

2.  3D bioprinting of tissues and organs.

Authors:  Sean V Murphy; Anthony Atala
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

Review 3.  Tissue engineering.

Authors:  R Langer; J P Vacanti
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

4.  Layered smooth muscle cell-endothelial progenitor cell sheets derived from the bone marrow augment postinfarction ventricular function.

Authors:  Yasuhiro Shudo; Andrew B Goldstone; Jeffrey E Cohen; Jay B Patel; Michael S Hopkins; Amanda N Steele; Bryan B Edwards; Masashi Kawamura; Shigeru Miyagawa; Yoshiki Sawa; Y Joseph Woo
Journal:  J Thorac Cardiovasc Surg       Date:  2017-05-24       Impact factor: 5.209

5.  A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic Cardiomyopathy.

Authors:  Yasuhiro Shudo; Jeffrey E Cohen; John W MacArthur; Andrew B Goldstone; Satoru Otsuru; Alen Trubelja; Jay Patel; Bryan B Edwards; George Hung; Alexander S Fairman; Christopher Brusalis; William Hiesinger; Pavan Atluri; Arudo Hiraoka; Shigeru Miyagawa; Yoshiki Sawa; Y Joseph Woo
Journal:  Tissue Eng Part A       Date:  2015-09-18       Impact factor: 3.845

6.  Isolation and trans-differentiation of mesenchymal stromal cells into smooth muscle cells: Utility and applicability for cell-sheet engineering.

Authors:  Yasuhiro Shudo; Jeffrey E Cohen; Andrew B Goldstone; John W MacArthur; Jay Patel; Bryan B Edwards; Michael S Hopkins; Amanda N Steele; Lydia-Marie Joubert; Shigeru Miyagawa; Yoshiki Sawa; Y Joseph Woo
Journal:  Cytotherapy       Date:  2016-04       Impact factor: 5.414

7.  Static linear and nonlinear elastic properties of normal and arterialized venous tissue in dog and man.

Authors:  R L Wesly; R N Vaishnav; J C Fuchs; D J Patel; J C Greenfield
Journal:  Circ Res       Date:  1975-10       Impact factor: 17.367

8.  Addition of mesenchymal stem cells enhances the therapeutic effects of skeletal myoblast cell-sheet transplantation in a rat ischemic cardiomyopathy model.

Authors:  Yasuhiro Shudo; Shigeru Miyagawa; Hanayuki Ohkura; Satsuki Fukushima; Atsuhiro Saito; Motoko Shiozaki; Naomasa Kawaguchi; Nariaki Matsuura; Tatsuya Shimizu; Teruo Okano; Akifumi Matsuyama; Yoshiki Sawa
Journal:  Tissue Eng Part A       Date:  2014-01-03       Impact factor: 3.845

9.  Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct.

Authors:  Pavan Atluri; Alen Trubelja; Alexander S Fairman; Philip Hsiao; John W MacArthur; Jeffrey E Cohen; Yasuhiro Shudo; John R Frederick; Y Joseph Woo
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

10.  Spatially oriented, temporally sequential smooth muscle cell-endothelial progenitor cell bi-level cell sheet neovascularizes ischemic myocardium.

Authors:  Yasuhiro Shudo; Jeffrey E Cohen; John W Macarthur; Pavan Atluri; Philip F Hsiao; Elaine C Yang; Alexander S Fairman; Alen Trubelja; Jay Patel; Shigeru Miyagawa; Yoshiki Sawa; Y Joseph Woo
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.